Connect with us

Health

Ukraine’s Healthcare Reforms Align with EU Standards Amid Ongoing War, Says WHO Official

Published

on

Kyiv, Ukraine – Ukraine’s healthcare system, under immense strain from the ongoing war with Russia, is simultaneously undergoing critical reforms aimed at aligning with European Union (EU) standards. According to a senior official from the World Health Organization (WHO), these efforts are positioning Ukraine to meet key EU regulations, even as the country grapples with daily attacks on its health facilities.

Jarno Habicht, head of the WHO office in Ukraine, highlighted the country’s dual challenge of addressing immediate healthcare needs while preparing for future EU membership talks. “Ukraine is responding every day,” Habicht said in an interview with Euronews. “Ambulances are supporting civilians, but there is also the challenge of rebuilding destroyed infrastructure.”

Since Russia’s full-scale invasion, attacks on healthcare facilities have increased sharply, with nearly daily incidents reported since December 2023. Despite these challenges, Ukraine is continuing to push forward with health sector reforms initiated before the conflict. Habicht noted that these reforms are critical as Ukraine harmonizes its public health legislative framework with EU standards, a key step in the country’s eventual accession process.

Aligning Healthcare with EU Regulations

While healthcare policy largely remains under the control of individual EU member states, certain areas—such as cross-border patient movement—require greater alignment. Habicht emphasized the importance of harmonizing regulations to ensure consistency in healthcare for Ukrainians, both within the country and in neighboring EU states where many have sought care due to the war.

Several national health frameworks will need to be adjusted to EU law, including regulations on water quality, cosmetics, chemicals, and rules governing tobacco and alcohol. One critical area of focus is the pharmaceutical sector. Ukraine, once home to one of the largest drug manufacturing industries in Central and Eastern Europe, has seen a significant portion of its industry devastated by the conflict. Harmonizing drug manufacturing standards, regulatory practices, and marketing authorizations with EU guidelines will be essential as the country rebuilds.

In July 2022, Kyiv adopted a new law regulating pharmaceutical products, which aims to prepare the sector for alignment with EU standards. This, according to Habicht, is a key step in Ukraine’s path to EU membership. “Ukraine’s reform efforts and the required harmonization with EU legislation basically go in the same direction,” he said.

Health System Under Siege

Since the war began, the WHO has recorded 1,940 attacks on healthcare facilities in Ukraine, the highest number in any humanitarian crisis to date. In addition to direct strikes on hospitals and clinics, critical infrastructure such as energy systems has been severely impacted. Russia’s large-scale attacks on Ukraine’s power grid have left millions without reliable access to electricity, heating, and water—further complicating the delivery of essential healthcare services.

Habicht warned that as winter approaches, the situation could worsen. “The latest estimate shows the average Ukrainian household is without electricity for six hours a day,” he said. This lack of power is not only affecting healthcare facilities but also schools, businesses, and homes across 20 of Ukraine’s 24 regions.

The war has also exacerbated poverty, with the national poverty rate rising from 7% to 25%. Many Ukrainians are now struggling to afford basic necessities, including medicine. Humanitarian organizations, supported by the WHO, are working to provide free medicines to approximately 12% of unemployed individuals in frontline areas.

Despite the dire circumstances, Ukraine continues its efforts to reform and rebuild, with its sights set on future integration with the EU.

Health

Scientists Warn of Health Risks from Fine Microplastics in Drinking Water

Published

on

By

A new study has highlighted the presence of fine microplastics in drinking water, urging the European Union (EU) to revise its detection standards to include smaller particles that may pose a greater risk to human health.

Researchers in Toulouse, France, found that most microplastics in bottled and tap water samples measured less than 20 microns (μm), a size small enough to potentially pass from the human intestine into the bloodstream and organs. Current EU guidelines only require monitoring of particles between 20 μm and 5 mm, leaving these finer plastics largely undetected.

Majority of Microplastics Found Are Under 20 Microns

The study, published in PLOS Water, tested 10 bottled water brands and one tap water source using a new method capable of detecting microplastics smaller than 20 μm. Results showed that 98% of the microplastics detected were below this threshold, with 94% measuring less than 10 μm in diameter.

“The idea was to prove it’s possible to analyze very fine plastics and to show the European Union that setting the detection limit at 20 microns makes little sense,” said Oskar Hagelskjaer, CEO of Microplastic Solution and the study’s lead author.

The researchers found microplastic concentrations ranging from 19 to 1,154 particles per liter, with the tap water sample from Toulouse containing 413 particles per liter—higher than most bottled water samples.

Advanced Detection Methodology

The study employed enhanced instrumentation and rigorous quality control to prevent sample contamination, offering a more accurate assessment of microplastic prevalence.

Bethanie Carney Almroth, a professor of ecotoxicology at the University of Gothenburg, Sweden, called the methodology “quite strong,” noting the researchers’ careful consideration of potential contamination and measurement accuracy.

Microplastics in Bottled vs. Tap Water

While bottled water was packaged in polyethylene terephthalate (PET) bottles, PET was not the most prevalent plastic found in the samples. Researchers speculate that factors such as tap water filtration processes or river contamination may contribute more significantly to microplastic presence.

Groundwater-sourced drinking water, which undergoes natural soil filtration, showed significantly lower microplastic concentrations compared to treated surface water, the study found.

Health Concerns and Global Impact

The health implications of microplastic exposure remain uncertain, though their ubiquity raises concerns. “They’re finding them everywhere they look. We know we have them in our bodies,” Almroth said, adding that emerging evidence suggests potential health impacts.

Researchers described microplastic contamination as a “pervasive problem,” noting that no region on the planet remains unaffected. The findings call for immediate action to address the risks associated with microplastics in drinking water and the broader environment.

Continue Reading

Health

Obesity Linked to Poorer Outcomes in Childhood Cancer Patients, Study Finds

Published

on

By

Children with obesity diagnosed with cancer face significantly worse health outcomes, including a heightened risk of relapse and death, according to a new Canadian study.

The research, published in the journal Cancer, analyzed data from over 11,000 cancer patients aged 2 to 19, of whom 10.5% were obese at diagnosis. The study examined various cancers, including leukemia, lymphoma, and other tumors, and found that obesity negatively impacted outcomes across the entire cohort.

Increased Risk of Relapse and Mortality

The findings revealed that obese children had a 16% higher risk of cancer relapse and a 29% increased risk of death within five years of diagnosis, even after accounting for factors such as age, sex, and ethnicity.

“Our study highlights the negative impact of obesity among all types of childhood cancers,” said Dr. Thai Hoa Tran, a pediatric hematologist and oncologist at the University Hospital Centre Sainte-Justine in Montreal, Canada, and one of the study’s authors.

Dr. Tran emphasized the need for strategies to address obesity’s impact on cancer outcomes in future clinical trials and highlighted the importance of combating the childhood obesity epidemic to prevent severe health consequences.

Acute Lymphoblastic Leukemia and Brain Tumors Most Affected

The study found the impact of obesity was particularly pronounced in children with acute lymphoblastic leukemia (ALL)—a cancer of the blood and bone marrow—and brain tumors. Researchers suggested that fat tissue may play an active role in tumor progression, metastasis, and resistance to treatment.

Previous research has indicated that adipose (fat) tissue cells can promote tumor development and hinder the effectiveness of therapies. Additionally, the study noted concerns about potential undertreatment and inappropriate dosing of chemotherapy in obese patients, which could further compromise outcomes.

Limitations and Calls for Improved Measures

The researchers acknowledged limitations in their study, including reliance on body mass index (BMI) to define obesity. They pointed out that BMI is an imprecise measure that does not fully capture body composition or nutritional status.

“BMI remains a crude and imperfect measure,” the authors wrote, echoing recent calls from experts to adopt more accurate diagnostic tools for obesity. Critics argue that BMI may lead to overdiagnosis or fail to reflect the nuanced impact of weight on health outcomes.

Implications and Urgency

The findings underscore the urgent need for interventions targeting childhood obesity and call for more precise research to better understand the interplay between obesity and cancer treatment. As childhood obesity rates continue to rise globally, addressing this epidemic could have far-reaching implications for improving survival rates and health outcomes for young cancer patients.

Continue Reading

Health

Tanzania Reports Deadly Marburg Virus Outbreak, Eight Fatalities Confirmed

Published

on

By

Tanzania is grappling with an outbreak of the highly lethal Marburg virus, with eight fatalities confirmed so far, global health authorities reported.

The World Health Organization (WHO) identified the outbreak in the Biharamulo and Muleba districts of the Kagera region, an Eastern African transit hub. As of January 11, nine suspected cases have been reported, including healthcare workers. The Marburg virus, which is related to Ebola, has a case fatality rate of up to 89%, according to WHO officials.

Symptoms and Transmission

WHO said the suspected patients displayed classic symptoms of Marburg, such as high fever, headache, back pain, diarrhea, vomiting with blood, and severe physical weakness. In later stages, external hemorrhaging may occur.

The virus is transmitted through contact with bodily fluids of infected individuals or contaminated surfaces, putting healthcare workers and close contacts at heightened risk.

“There is an expectation of further cases as disease surveillance improves,” WHO Director-General Tedros Adhanom Ghebreyesus said in a social media update.

Containment Efforts Underway

Rapid response teams have been deployed to the affected areas to investigate and contain the outbreak. Authorities are tracing contacts of infected individuals, setting up treatment centers, and enhancing public awareness to prevent further spread.

However, officials caution that detection and isolation of cases have been delayed due to the Kagera region’s role as a transit hub, which may have facilitated the virus’s spread.

Neighbouring countries, including Rwanda, Uganda, Burundi, and the Democratic Republic of the Congo, have been urged to remain vigilant. “We recommend neighbouring countries be on alert and prepared to manage potential cases,” Tedros said.

No Approved Vaccine or Treatment

Marburg virus outbreaks are rare but severe, with fatality rates ranging from 24% to 88%. There is currently no authorized vaccine or treatment, although experimental options are being tested.

In 2023, a similar outbreak occurred in Tanzania’s Kagera region, resulting in nine cases and six deaths. Another outbreak in Rwanda last year sickened 66 people and caused 15 deaths before being declared over in December.

Zoonotic reservoirs, such as fruit bats, are believed to play a role in the virus’s transmission and remain endemic to the region, WHO noted.

Global Risk Assessment

While the risk of global spread is low, WHO considers the threat high for Tanzania and its regional neighbors. Health authorities are focusing on containing the outbreak swiftly to prevent a broader crisis.

“Marburg virus outbreaks underscore the need for robust surveillance systems and rapid response measures to protect public health,” the agency said in a statement.

Continue Reading

Trending